Sign in


Panama City, FL
October 11, 2019

Contact this candidate




*****009 M.D.: Fellowship in Endocrinology, Diabetes & Metabolism: SUNY Buffalo, New York, US

**** – 2006 F.C.P.S (Internal Medicine): College of Physicians & Surgeons of Bombay, India

1997 – 2002 M.B.B.S: University of Mumbai, India


01/2018 – Present Endocrinologist at IEDHH, Panama City, Florida, US

01/2014 – 12/2017 Endocrinologist & Head of Dept, Seven Hills hospital, Mumbai, India

09/2012 – 10/2013 Endocrinologist, Vera Endocrine Associates, Daytona Beach, Florida, US

07/2009 – 08/2012 Endocrinologist, Premier Medical Associates, Lady Lake, Florida, US


2009 – Present Florida Board of Medicine, US: Physician License # 105081. Active DEA / Controlled Substance /

Dispensing Practitioner

09/2019 – 08/2021 Georgia Composite Medical Board Physician License # 84158

10/2019 – 07/2020 New Mexico Medical Board Physician License # MD2019-0884

2013 FACE (Fellow, American College of Endocrinology): US

2009 ACE-Endocrine University, Mayo Clinic, US:

Endocrine Neck Ultrasound & Thyroid FNA biopsy

CCD (Certified Clinical Densitometrist) by ISCD

Intensive Insulin Management & Technology

Laboratory Director Training Program (COLA/ACE): moderate-complexity lab

2007 Certified in Internal Medicine: Medical Council of India

2006 USMLE Step III (score 86) & ECFMG Certification, Valid Indefinitely

2004 / 2015 / 2017 ACLS, BLS (Advanced Cardiac & Basic – Life Support)

2002 – 2003 USMLE I (score 99), II (score 99) & II CS

2003 Medical practitioner: Registered with Medical Council of India


Endocrine Society; American Association of Clinical Endocrinologists: Pituitary, Gonad, Adrenal, Neuro-Endocrine, Thyroid, Lipids & CV Disease State Networks; American Diabetes Association; National Osteoporosis Foundation Ambassador


A. Academic/ Professional

2009 ESAP – ITE (Endocrine Self-Assessment Program In-Training Examination) National Rank Top

Percentile; Dept Rank 1, US

2008 Cheryl Kisbaugh Resident Professionalism Award, University of Buffalo, NY, US

2007 Lilly Endocrine Scholars Award (USD 47,000) Endocrine Society, ENDO Toronto, Canada

2007 International Endocrine Physician Travel Grant (poster; USD 2000), AACE, US

2006 AACE Roll of Honor: Power of Prevention, US: School project to combat childhood obesity

2006 International Diabetes Federation (IDF) Education Foundation – Mary Jane Mayes 2005 Fund (USD

4000): Short Training Fellowship in Diabetes, US. India’s First & Only IDF Scholar

2006 Top Ranker in Clinical Exam of Diabetology. 3rd overall. University of Mumbai, India

1997 – 2002 Medical College: Distinctions in Pharmacology, Microbiology & Immunology & Biochemistry.

1st class, 1st attempt. Mumbai, India

B. Extra – curricular

2000 – 2003 Citation for All Rounder & Sportsperson of Medical School

1990 – 2013 Best Boy (The Society of St. Peter’s Medal), Best Actor, Best Debater; accolades in penmanship,

essay writing, elocution, athletics


2012 – Present Chairman / Moderator / Member: Advisory Boards of International & Indian Pharmaceutical

companies for diabetes /endocrine therapeutics: DPP4/SGLT2 inhibitors, Statins, Thyroid drugs,

Insulins, GLP1 analogs: US & India

2006 – Present Endocrine lectures for health professionals, community health organizations & laity: US & India

PUBLICATIONS (select only)

1. Topiwala S, Agrawal R. Unusual thyroid cancer patient with unique diagnostic & therapeutic challenges. Endocrine Practice

Vol 24 Supp 1, Pg 253-254. AACE 27th Annual Scientific & Clinical Congress Abstracts, April 2018, USA

2. Topiwala S, Dhindsa S. Hypogonadism and Obesity. Journal of General Medicine Vol 21, No. 1,48 – 52. Jan 2009

3. Topiwala S et al.Testosterone concentrations in young patients with diabetes. Diabetes Care, 31(10): 2013-7, Oct 2008

4. Dandona P, Topiwala S. Hypogonadotrophic hypogonadism in type 2 diabetes. Aging Male, 11(3): 107-17, Sept 2008

MISCELLANEOUS: Judge of others’ work / Literary – Media activities

2016 – 2019 Editorial Board of Endocrine News (USA Endocrine Society’s feature magazine circulated globally).

Abstract Reviewer for ENDO 2018, 2019, 2020 (Endocrine Society Annual Meetings), USA

2018 Textbook: ‘Practice Pearls in Type 2 Diabetes: Indian perspective’: chapter contribution.

ISBN: 978-9-38-837600-6. 1st edition. Published by Intas pharmaceuticals & MVD healthcare

2018 ‘Why Not Endocrinology’, Endocrine News article (April)

2015, 2016 India Today Magazine articles on Diabetes; RadioCity FM messages on World Heart / Diabetes Day

2014 – Present India Associate for and

2009 – 2018 Endocrine Expert for &

2011 ‘First year of private practice: Premeditate to Preempt Predicaments’, Endocrine News article (April)

2009 – 2014 Reviewer of Academic/Research Award applications for a leading endocrine society

2009 – Present Reviewer for indexed journals 1) ENDOCRINE 2) 2016 - Present: Journal of Endocrine Society

2006 VIDEO: Diabetes Education in English, Hindi & Gujarati

2004 Acknowledged in the 6thedition of the Oxford Handbook of Clinical Medicine and its mini version

(2006) for rectifying 70 factual & typographical errors

1999 – 2003 Articles in Annual Medical School Magazine

1997 Editor of PATHFINDER, a quarterly newsletter of Scouts group


2004 – Present Educating Medical Assistants (MAs), Licensed Practical Nurses (LPNs), Phlebotomy & Radiology technicians, Nurses’ Aids, Laboratory personnel, Registered Nurses (RNs), Physician Assistants (PAs), Nurse Practitioners (NPs), Registered Dietitians (RDs), Certified Diabetes educators (CDEs), Pharmacists, Pharmacy technicians, Occupational / Physio-therapists, Interns, Family Medicine / Internal Medicine / Urgent Care / Emergency Medicine / OBGYN Residents & Physicians (MDs) in private practice: Training in bedside/ward clinics, tutorials, exams, OPD/Rounds, emergencies, procedures) on Endocrine-Diabetes clinical care – US & INDIA

2014 – 2017 INDIA: Faculty: ADE (Association of Diabetes Educators), Indian Dietetics Association & ISBMR (Indian Society of Bone Mineral Research); International Faculty for electronic Diabetes Educators Course (eDEC) India; Attending physician for D.N.B Internal / General medicine post graduate residents at Seven Hills hospital academic program (accredited by NBE); MMC (Maharashtra Medical Council) Accredited Speaker

2006 – 2009 Endocrine modules for UB School of Medicine & D’Youville College Physician Assistant & Pharmacology Programs, Buffalo, NY, US

2007 – 2009 Faculty: Clinical Assistant Instructor of Medicine, University of Buffalo, NY, US

2005 – 2006 Faculty: WHO (World Health Organization) – International Diabetes Center Staged Diabetes Management “Train the Trainer” Programme, India


English, Hindi, Gujarati, Urdu, Marathi


(more available upon request)

Vishal Bhatia, MD, FACE

Director of Endocrinology, St Mary’s Joslin Diabetes Center

3801 Bellemeade avenue, Suite 110, Bellemeade Medical Office Bldg, Evansville, Indiana 47714 US

Tel: 812-***-**** Fax: 812-***-**** Email:

Cover Letter of Shehzad Topiwala, MD, FACE

‘Interventional’ Endocrinologist

After completing an ACGME/ABIM accredited Clinical Fellowship in Endocrinology at SUNY Buffalo in 2009, I joined a group practice in central Florida as Chief of Endocrine services. I relocated to Daytona Beach, Florida in 2012 to affiliate with Vera Endocrine Associates. During my fifth year of practice in America, I began to explore larger metropolitan cities to set up my own office. But in 2014, I accepted an enticing offer from India as Head of Endocrinology department at the nationally acclaimed Seven Hills Healthcare City in Mumbai. It is one of the largest tertiary-care hospitals in Asia. I eventually relocated to US from 2018 by joining a comprehensive Endocrine-Diabetes Institute in northwest Florida.

A 2001 Mumbai University MBBS graduate, I completed an Internal Medicine residency from CPS (College of Physicians & Surgeons of) Bombay, & a Diploma in Diabetology from Seth GS Medical College & KEM Hospital (through University of Mumbai), which is one of India’s (& indeed, Asia’s) finest teaching hospitals & academic institutions. The university program entailed training in the department of Endocrinology. Following this, I was a Consultant Diabetologist/ Bariatric & Cardio-Metabolic physician in private practice for some time until I was conferred with the prestigious IDF (International Diabetes Federation) Award for a visiting Fellowship in US. Thereafter, at the outset of my clinical fellowship I was bestowed with the coveted Lilly Endocrine Scholars award by the esteemed Endocrine Society (ES) at the 2007 annual ENDO meeting, granted annually to only 1 fellow nationwide across America. (Some years later, I was on the selection panel for reviewing applications for the same award for endocrine fellows in US). During my fellowship, I was further honored with the Resident Professionalism Award, from over 700 resident physicians at University of Buffalo (UB), followed by a top departmental rank in the national endocrine training exam towards the end of my program. Whilst at UB, I served as Faculty in their School of Medicine as Clinical Assistant Instructor. In 2013, I was recognized as a Fellow of the American College of Endocrinology (F.A.C.E.) at the annual convocation.

I am formally certified in Bone densitometry, Neck Ultrasound & Thyroid Biopsies, Intensive Insulin therapy, & Laboratory Directorship. Since 2013, various pharmaceutical companies have contracted me for their loco-regional, national & international Speaker Bureau as Endocrine faculty to disseminate clinical knowledge of their endocrine- diabetes portfolio to other health care providers across the globe.

As member of the Trainee & Career Development Core Committee of the ES, I contributed to the shaping of clinical & curricular training of endocrine fellows in US. I also enjoyed serving on the AACE Technology Development committee for several years. I am well published and serve as a peer reviewer for an indexed endocrine journal. For the next 2 years, I am on the editorial board of Endocrine News, ES’ flagship global magazine. Recently I champion the cause of Bone health in Florida’s panhandle via NOF’s Ambassadorship program.

I thrive in prolific activity (out/in-patient consults, satellite clinics, Interventional Procedures (with CPT codes): provocative endocrine testing protocols (eg. ACTH stimulation test), Ultrasound-guided Fine Needle Aspirations of thyroid nodules with on-site diagnostic cyto-pathology & molecular genetic testing, high-resolution Ultrasound of Thyroid & Abdomen / FibroScan (for Fatty liver screening), Hormone pellet insertions, Infusion/administration of metabolic & biologic pharmaco-therapeutic agents (such as anti-osteoporosis medications), CSII i.e. automated hybrid closed-loop Insulin pumps (‘artificial pancreas’), CGMS (i.e. real-time glucose sensors & Implants), Spirometry/FEV1 for Inhaled Insulin use, Body Composition-Metabolism Analyses & Weight management devices, limb arterial Doppler, Autonomic neuropathy testing, digital Retina scans, ambulatory BP monitoring, MNT (Medical Nutrition Therapy), accredited DSMT (Diabetes Self Management Training), Home sleep testing (for Obstructive Sleep Apnea evaluation) & Thyroid cancer Radionuclide/Iodine thera-nostics.

I am the co-director of a Center of Excellence in the region, catering to Bariatrics, Diabetes, Lipidology, Thyroidology & General Endocrinology. We are a host site for Clinical Trials as well as medical school student/resident rotations for Alabama College of Medicine. Furthermore, we also run a full-fledged Aesthetics program (= Medical Spa offering Body Contouring, Trichology, Laser hair reduction, Botox, Lymphatic drainage, Varicose vein obliterations & more).

I have over a decade of post-graduate experience. I am a well-rounded individual with excellent academic & co- curricular credentials, including sports, journalism, public speaking (multi-lingual), community service & leadership. Always charged about my work, I am a dynamic endocrinologist committed to evidence-based medicine. I typify the new millennium physician, fully tapping technology to optimize health care delivery. I entertain patients as I have a penchant for fun. Flair for administrative work is another trait I cherish.

Beside the most gratifying duty of managing a diverse array of clinical endocrine conditions, the ideal platform for me would be one with a blend of academics, teaching & clinical research.

At the end of the day, I consider myself blessed with the opportunity to serve mankind, and strive to do so in all humility.

Please note I am at a point in my career (in my 11th year of practice post-fellowship) where I am keen to settle in one place & would invest financially into a prospective position to demonstrate my long-term commitment.


SHORT ANSWER: I am eligible for Endocrine boards but I must either undergo 2-3 years of an Internal Medicine residency in US or work at Assistant Professor level in academia for 3 years. Candidly I am not sure if I will ever pursue securing board certification, because I am fairly advanced, stable & content at this stage of my career.


Indeed, for ‘exceptionally qualified international graduate applicants’, the Accreditation Council for Graduate Medical Education (ACGME) permits accredited Endocrinology Fellowship training in US even if an (unaccredited) Internal Medicine (IM) residency is completed outside US (e.g. India, as in my case).

The following is the official web-page link to ACGME Program Requirements for Graduate Medical Education in Endocrinology, Diabetes, and Metabolism (Subspecialty of Internal Medicine): Please refer to Pages 16 and 17 of 54 under III.A.1.c).(1) (a), (b), (c) & III.A.1.c).(2)

However, such accredited fellowship-trained physicians are not directly eligible for American Board of Internal Medicine (ABIM) sub-specialty certification in Endocrinology. (See page 17 under III.A.1.c). (2) : 'Applicants being considered for these positions must be informed of the fact that their training may not lead to certification by ABMS member boards or AOA certifying boards.' )

If they desire to acquire ABIM Endocrine board eligibility/certification, they must repeat an accredited IM residency in US and get Board Certified (BC) in IM first. Then they can straight away sit for Endo boards. Owing to this unique circumstance, the unconventional route to Endo boards would be:

non-US/unaccredited IM residency accredited US Endo fellowship accredited US IM residency IM boards Endo boards.

So I graduated from an ACGME-accredited Endocrinology Fellowship program in US even though my IM residency was completed in India. URL links to my fellowship training are

But if I really wanted to get BC in Endocrinology, ABIM still acknowledges my fellowship training & will allow me to sit for the Endocrine board exams long as I attain BC in IM which in turn entails EITHER:

1) (re-)doing an IM residency in US. (Some residency programs waive 1 of the 3 years, recognizing the fact that an unaccredited IM residency was successfully completed abroad. I am not keen on opting for this track)


2) Complying with ABIM regulations on Candidates for Special Consideration = Pathway A for International Medical Graduates which requires at least 3 years’ academic rank at Assistant Professor or higher, as full-time US faculty.

(I am open to this option but again University settings invariably expect the incumbent Endocrinologist to be already BE/BC.)

After attaining BC in IM, I can directly sit for Endocrine boards.

I chose not to pursue BC in IM as it would be a redundant & retrogressive step, because ever since my fellowship completion in US in 2009, I have been practising 100% Endocrinology only.

My first employed Endocrinology position was with a large multi-specialty group (2009-2012) along with 2 major hospital privileges, while the second was with a single-specialty Endocrine out-patient office (2012-2013), both in Florida.

Then I temporarily moved to India for a few years from 2014-2017, again practising only Adult Endocrinology there. I relocated to US from January 2018 by joining a premier Endocrine office-based practice in Northwest Florida. I possess a clear, active, full & unrestricted medical doctor license in Florida (with no malpractice issues ever & a clear NPDB record), the most recent validity being until 2021 marking 10-plus consecutive years of medical licensure in Florida. I subsequently acquired Georgia & New Mexico Medical Board licenses seamlessly in 2019. I have been considering some job offers from these states so I reckoned it would be prudent to keep these licenses ready just in case.

I am fully credentialed with Medicare / Tricare / Medicaid as well as all major commercial insurance payors (BCBS, United, Humana, Cigna) in Florida, because generally in almost all states, one's board status is typically immaterial to licensure / medico-legal ability to practise. Federal facilities like Veterans Affairs Medical Centers/Dept of Defence do not even mandate board status, because any active US state license suffices.

Contact this candidate